glp 1 drugs and depression GLP-1 medications used to treat diabetes obesity may also help alleviate symptoms of anxiety and Part 2 of a 3-Part
Description
In clinical trials, it led to a weight reduction of up to 16.2%
Constipation occurs in
However, GLP-1 RAs significantly increased the change in the 6-min walk test (MWT) distance (MD: 19.74, p = 0.002)
00014-3/asset/c6c68f71-1303-4dbd-81fc-c7e57d64925d/main.assets/gr2_lrg.jpg)
Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
Learn more about these findings:
